Fig. 3From: Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapyDisease free and overall survival in previously untreated patients with peripheral tumors deemed to be medically inoperable after being treated with Cyberknife SBRT. a The median progression-free survival was estimated to be 28.5Â months (95Â % CI: 15.8Â months to not reached). The overall disease-free survival at 3Â years was 37.5Â % (95Â % CI: 17.7- 57.4Â %). b The overall survival at 3Â years (36Â months) was 62.4Â % (95Â % CI: 74.3-47.3Â %). The median overall survival time was not reachedBack to article page